Back to Results
First PageMeta Content



Head and Neck Cancer Clinical Trials NRG-HN001 ** Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV)
Add to Reading List

Document Date: 2016-01-22 15:47:50


Open Document

File Size: 242,43 KB

Share Result on Facebook